More interestingly, animal studies have proved that DPP4 activity inhibitors ameliorated cognitive impairment through suppressing inflammatory reaction, oxidative stress, or GLP-1 degradation (Gault et al., 2015; Ma et al., 2015; Tsai et al., 2015). The gene discussed is GCG; the disease is Cognitive impairment.